Antares Pharma, Inc.-Product Pipeline Review-2015

Antares Pharma, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07141CDB
  • |
  • Pages: 29
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Antares Pharma, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Antares Pharma, Inc.-Product Pipeline Review-2015', provides an overview of the Antares Pharma, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Antares Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Antares Pharma, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Antares Pharma, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Antares Pharma, Inc.'s pipeline products

Reasons To Buy

Evaluate Antares Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Antares Pharma, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Antares Pharma, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Antares Pharma, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Antares Pharma, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Antares Pharma, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Antares Pharma, Inc. Snapshot 4

Antares Pharma, Inc. Overview 4

Key Information 4

Key Facts 4

Antares Pharma, Inc.-Research and Development Overview 5

Key Therapeutic Areas 5

Antares Pharma, Inc.-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Pipeline Products-Combination Treatment Modalities 9

Antares Pharma, Inc.-Pipeline Products Glance 10

Antares Pharma, Inc.-Late Stage Pipeline Products 10

Phase III Products/Combination Treatment Modalities 10

Antares Pharma, Inc.-Clinical Stage Pipeline Products 11

Phase II Products/Combination Treatment Modalities 11

Antares Pharma, Inc.-Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Antares Pharma, Inc.-Drug Profiles 13

testosterone enanthate 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

(nestorone + estradiol) 14

Product Description 14

Mechanism of Action 14

R&D Progress 14


Product Description 16

Mechanism of Action 16

R&D Progress 16

Antares Pharma, Inc.-Pipeline Analysis 17

Antares Pharma, Inc.-Pipeline Products by Target 17

Antares Pharma, Inc.-Pipeline Products by Route of Administration 18

Antares Pharma, Inc.-Pipeline Products by Molecule Type 19

Antares Pharma, Inc.-Pipeline Products by Mechanism of Action 20

Antares Pharma, Inc.-Recent Pipeline Updates 21

Antares Pharma, Inc.-Dormant Projects 23

Antares Pharma, Inc.-Company Statement 24

Antares Pharma, Inc.-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Appendix 28

Methodology 28

Coverage 28

Secondary Research 28

Primary Research 28

Expert Panel Validation 28

Contact Us 28

Disclaimer 29

List of Tables

Antares Pharma, Inc., Key Information 4

Antares Pharma, Inc., Key Facts 4

Antares Pharma, Inc.-Pipeline by Indication, 2015 6

Antares Pharma, Inc.-Pipeline by Stage of Development, 2015 7

Antares Pharma, Inc.-Monotherapy Products in Pipeline, 2015 8

Antares Pharma, Inc.-Combination Treatment Modalities in Pipeline, 2015 9

Antares Pharma, Inc.-Phase III, 2015 10

Antares Pharma, Inc.-Phase II, 2015 11

Antares Pharma, Inc.-Preclinical, 2015 12

Antares Pharma, Inc.-Pipeline by Target, 2015 17

Antares Pharma, Inc.-Pipeline by Route of Administration, 2015 18

Antares Pharma, Inc.-Pipeline by Molecule Type, 2015 19

Antares Pharma, Inc.-Pipeline Products by Mechanism of Action, 2015 20

Antares Pharma, Inc.-Recent Pipeline Updates, 2015 21

Antares Pharma, Inc.-Dormant Developmental Projects,2015 23

Antares Pharma, Inc., Other Locations 27

Antares Pharma, Inc., Subsidiaries 27

List of Figures

Antares Pharma, Inc.-Pipeline by Top 10 Indication, 2015 6

Antares Pharma, Inc.-Pipeline by Stage of Development, 2015 7

Antares Pharma, Inc.-Monotherapy Products in Pipeline, 2015 8

Antares Pharma, Inc.-Pipeline by Top 10 Target, 2015 17

Antares Pharma, Inc.-Pipeline by Top 10 Route of Administration, 2015 18

Antares Pharma, Inc.-Pipeline by Top 10 Molecule Type, 2015 19

Antares Pharma, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Antares Pharma, Inc.; Antares Pharma, Inc. - Key Therapeutics; Antares Pharma, Inc. - Pipeline Overview and Promising Molecules; Antares Pharma, Inc. - News; Antares Pharma, Inc. - Latest Updates; Antares Pharma, Inc. - Pipeline; Antares Pharma, Inc. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 95295
Site License
USD 3000 INR 190590
Corporate User License
USD 4500 INR 285885



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]